Min Min Yang
Director Ejecutivo en PHARMABLOCK SCIENCES (NANJING), INC. .
Fortuna: 192 M $ al 30/04/2024
Cargos activos de Min Min Yang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Presidente | 01/12/2014 | - |
| Director Ejecutivo | 21/04/2023 | - | |
| Fundador | 26/12/2006 | - | |
| Director/Miembro de la Junta | 01/11/2014 | 01/12/2014 | |
| GEMPHARMATECH CO., LTD. | Director/Miembro de la Junta | 19/10/2023 | - |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 01/03/2021 | - |
| Independent Dir/Board Member | 01/03/2021 | - |
Historial de carrera de Min Min Yang
Formación de Min Min Yang.
| Nanjing University | Graduate Degree |
| Auburn University | Doctorate Degree |
Estadísticas
Internacional
| China | 5 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
| GEMPHARMATECH CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Min Min Yang
- Experiencia
